Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro

Neuroscience Letters

Volumn 91, Issue 2, 1988, Pages 211-216

  Perry, E K ^a   Smith, C J ^a   Court, J A ^a   Bonham, J R ^a   Rodway, M ^a   Atack, J R ^b  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

9 Amino 1,2,3,4 tetrahydroaminoacridine; Acetylcholinesterase; Human cortex in vitro; Muscarinic receptor; Nicotinic receptor; Physostigmine

Indexed keywords

ACETYLCHOLINESTERASE; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; PHYSOSTIGMINE; PIRENZEPINE; TACRINE;

AUTOPSY; BRAIN CORTEX; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME INHIBITION; HUMAN CELL; NICOTINIC ACID RECEPTOR; NORMAL HUMAN; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; AGED; AMINOACRIDINES; BINDING, COMPETITIVE; CEREBRAL CORTEX; HUMAN; MIDDLE AGE; PHYSOSTIGMINE; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; SUPPORT, NON-U.S. GOV'T; TACRINE;

EID: 0023755495     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(88)90770-7     Document Type: Article

References (14)

1. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human nervous systems
2. Acetylcholinesterase and butyrylcholinesterase measurement in the pre-natal detection of neural tube defects and other fetal malformations
3. Raising the ambient potassium ion concentration enhances carbachol stimulated phosphoinositide hydrolysis in rat hippocampal and cerebral cortical miniprisms
4. 9-Amino-1,2,3,4-tetrahydroaminoacridine (THA) an alleged drug for the treatment of Alzheimer's disease inhibits acetylcholinesterase activity and outward 1ct current
5. Cholinergic approaches to the treatment of Alzheimer's disease
6. Acetylcholinesterase generates enkephalin-like immunoreactivity when it degrades soluble proteins (chromogranins) from adrenal chromaffin granules
7. Enzyme inhibiting action of tetrahydroaminoacridine and its structural fragments
8. Do tetrahydroaminacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?
9. 9-Amino-1,2,3,4-tetrahydroaminoacridine (THA) is a potent blocker of cardiac potassium channels
10. Cholinergic receptors in cognitive disorders
11. Studies and possible functional coupling between presynaptic acetylcholinesterase and high affinity choline uptake in the rat brain
12. Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders
13. Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampus pyramidal neurons
14. Oral tetrahydroaminoacridine in long term treatment of senile dementia, Alzheimer type